Unimore Lifesciences Private Limited
Provides security guard services, training and placement, and distributes medicine and drugs.
2013 | Gorakhpur, Uttar Pradesh (India) | Active
Unimore Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -10.72%
- Ebitda -10.72%
- Net Worth -60.48%
- Total Assets -57.00%
About Unimore Lifesciences
Unimore Lifesciences Private Limited (ULPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 December 2013 and has a history of 11 years and two months. Its registered office is in Gorakhpur, Uttar Pradesh, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arti Srivastava and Praveen Kumar serve as directors at the Company.
Company Details
- Location
Gorakhpur, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900UP2013PTC061258
- Company No.
061258
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Business Services
Who are the key members and board of directors at Unimore Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arti Srivastava  | Director | 16-Dec-2013 | Current |
| Praveen Kumar | Director | 16-Dec-2013 | Current |
Financial Performance of Unimore Lifesciences.
Unimore Lifesciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 10.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 60.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unimore Lifesciences?
In 2017, Unimore Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Unimore Lifesciences?
Unlock and access historical data on people associated with Unimore Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unimore Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unimore Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.